Kuo YH - Search Results

1

Survival of patients with small cell lung carcinoma in Taiwan.

Kuo YH, Lin ZZ, Yang YY, Shao YY, Shau WY, Kuo RN, Yang JC, Lai MS. Kuo YH, et al. Among authors: kuo rn. Oncology. 2012;82(1):19-24. doi: 10.1159/000335084. Epub 2012 Jan 20. Oncology. 2012. PMID: 22269348

2

Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials.

Yang SH, Kuo YH, Tien YW, Hsu C, Hsu CH, Kuo SH, Cheng AL. Yang SH, et al. Among authors: kuo yh, kuo sh. Oncology. 2011;81(3-4):143-50. doi: 10.1159/000330817. Epub 2011 Oct 19. Oncology. 2011. PMID: 22024966

3

Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy.

Kuo YH, Lin CH, Shau WY, Chen TJ, Yang SH, Huang SM, Hsu C, Lu YS, Cheng AL. Kuo YH, et al. BMC Cancer. 2012 Dec 26;12:620. doi: 10.1186/1471-2407-12-620. BMC Cancer. 2012. PMID: 23268621 Free PMC article.

4

Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking.

Kuo YH, Shiau AL, Tung CL, Su YC, Li CF, Su BH, Tsao CJ, Wu CL, Feng YH, Wu P. Kuo YH, et al. Oncol Lett. 2019 Jun;17(6):5740-5746. doi: 10.3892/ol.2019.10248. Epub 2019 Apr 12. Oncol Lett. 2019. PMID: 31105795 Free PMC article.

5

Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study.

Chu SS, Kuo YH, Liu WS, Wang SC, Ho CH, Chen YC, Yang CC, Wu HC. Chu SS, et al. Among authors: kuo yh. Sci Rep. 2021 Jan 15;11(1):1614. doi: 10.1038/s41598-021-81176-w. Sci Rep. 2021. PMID: 33452421 Free PMC article.

6

Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.

Kang NW, Tan KT, Li CF, Kuo YH. Kang NW, et al. Among authors: kuo yh. Curr Oncol. 2021 Nov 10;28(6):4587-4596. doi: 10.3390/curroncol28060388. Curr Oncol. 2021. PMID: 34898561 Free PMC article.

7

Formin-Like 2 Is a Potential Biomarker of Poor Prognosis in Nasopharyngeal Carcinoma.

Lee SW, Yang CC, Lai HY, Tsai HH, Yeh CF, Kuo YH, Kang NW, Chen TJ, Chang SL. Lee SW, et al. Among authors: kuo yh. Oncology. 2022;100(9):475-484. doi: 10.1159/000525682. Epub 2022 Jun 30. Oncology. 2022. PMID: 35772391

8

High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.

Li WM, Ke HL, Kuo YH, Lai HY, Chan TC, Hsing CH, Hsieh KL, Li WS, Chen TJ, Wei YC, Wu WJ, Huang SK, Li CF. Li WM, et al. Among authors: kuo yh. Oncology. 2022;100(9):485-497. doi: 10.1159/000525743. Epub 2022 Jul 11. Oncology. 2022. PMID: 35817020

9

Elovl6 is a poor prognostic predictor in breast cancer.

Feng YH, Chen WY, Kuo YH, Tung CL, Tsao CJ, Shiau AL, Wu CL. Feng YH, et al. Among authors: kuo yh. Oncol Lett. 2016 Jul;12(1):207-212. doi: 10.3892/ol.2016.4587. Epub 2016 May 16. Oncol Lett. 2016. PMID: 27347126 Free PMC article.

10

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.

Kuo YH, Chan TC, Lai HY, Chen TJ, Wu LC, Hsing CH, Li CF. Kuo YH, et al. Front Oncol. 2021 Sep 13;11:749142. doi: 10.3389/fonc.2021.749142. eCollection 2021. Front Oncol. 2021. PMID: 34589439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,224 results

Search Page

Filters